CYTOGENETIC CHANGES IN WHITE BLOOD CELLS AFTER CYCLOPHOSPHAMIDE TREATMENT

被引：26

作者：

BAUCHINGER, M

SCHMID, E

机构：

[1] Institut für Biologie der Gesellschaft für Strahlenforschung, München-Neuherberg und Strahlenbiologisches Institut der Universität München, München

来源：

ZEITSCHRIFT FUR KREBSFORSCHUNG | 1969年 / 72卷 / 01期

关键词：

D O I：

10.1007/BF00524798

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The chromosome analysis of 19 non-irradiated patients with ovarian tumours showed a mean of 15-20% chromosomal defects of all analysed cells. The corresponding value of non-irradiated tumour patients without cytostatic treatment was 2.5%. The number of breaks per analysed cell was about 10 times greater than in these controlls. Most of the defects are formed by aberrations of chromatids of the delayed-isolocus" type. The abnormalities increase with the number of single infusions and the dose of cyclophosphamide. © 1969 Springer-Verlag."

引用

页码：77 / +

页数：1

共 21 条

[1] ARRIGHI FE, 1962, TEX REP BIOL MED, V20, P545
[2] BAUCHINGER M, 1966, STRAHLENTHER ONKOL, V131, P109
[3] BAUCHINGER M, 1968, STRAHLENTHER ONKOL, V135, P553
[4] CASTOLDI G L, 1964, Nouv Rev Fr Hematol, V4, P395
[5] Hampel K E, 1968, Int Z Klin Pharmakol Ther Toxikol, V1, P322
[6] ACTION OF CYTOSTATIC AGENTS ON CHROMOSOMES OF HUMAN LEUKOCYTES IN VITRO (PRELIMINARY COMMUNICATION)
HAMPEL, KE
KOBER, B
ROSCH, D
GERHARTZ, H
MEINIG, KH
[J]. BLOOD-THE JOURNAL OF HEMATOLOGY, 1966, 27 (06): : 816 - +
[7] HAMPEL KE, 1964, HEREDITAS, V51, P315
[8] KOVACS ET, 1960, J NATL CANCER I, V24, P759
[9] MCLEISH J, 1953, HEREDITY S, V6, P125
[10] MICHAELIS A., 1961, BIOL ZENTRALBL, V80, P301

← 1 2 3 →